[Confidence Level: High] Synendos Therapeutics is a clinical-stage Swiss biotechnology organization pioneering Selective Endocannabinoid Reuptake Inhibitors (SERIs) to treat neuropsychiatric disorders like GAD and PTSD.26
[Confidence Level: High] Synendos Therapeutics is a clinical-stage Swiss biotechnology organization pioneering Selective Endocannabinoid Reuptake Inhibitors (SERIs) to treat neuropsychiatric disorders like GAD and PTSD.26
This is an extract of the full organization profile. To access the full company profile, .
Desktop only
The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.